alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet

RxCUI: 1368410
RxNorm name: alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Display name: alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Full name: alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Alogliptin and Pioglitazone	ALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDE	Padagis Israel Pharmaceuticals Ltd	642b1e90-701e-42f2-bac6-a4918738e2c9	2025-07-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1368410
OSENI	ALOGLIPTIN AND PIOGLITAZONE	Takeda Pharmaceuticals America, Inc.	4c619ed9-fe3e-4158-9938-80c6c3493d55	2025-02-28	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1368410

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
4c619ed9-fe3e-4158-9938-80c6c3493d55	alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [PSN] · alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [SCD] · alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet [SY]	3	23	These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 2013	20250228
642b1e90-701e-42f2-bac6-a4918738e2c9	alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [PSN] · alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [SCD] · alogliptin 12.5 MG (as alogliptin benzoate 17 MG) / pioglitazone 30 MG (as pioglitazone hydrochloride 33.06 MG) Oral Tablet [SY]	3	11	These highlights do not include all the information needed to use ALOGLIPTIN AND PIOGLITAZONE TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND PIOGLITAZONE TABLETS. Alogliptin and Pioglitazone Tablets, for oral use Initial U.S. Approval: 2013	20250728